Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 09-2010 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -116,484 | -123,096 | N/A | 78,500 | -452,900 |
| Depreciation Amortization | 1,646 | 740 | N/A | 63,800 | 476,700 |
| Income taxes - deferred | N/A | N/A | N/A | -300 | -5,800 |
| Accounts receivable | 192 | 895 | N/A | -56,100 | 41,700 |
| Accounts payable and accrued liabilities | -3,425 | -858 | N/A | 14,700 | -17,800 |
| Other Working Capital | -7,694 | 481 | N/A | -25,200 | -3,100 |
| Other Operating Activity | 4,184 | 476 | 0 | 61,200 | 41,100 |
| Operating Cash Flow | $-121,581 | $-121,362 | $N/A | $136,600 | $79,900 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -358 | -944 | N/A | -28,100 | -26,700 |
| Net Acquisitions | N/A | N/A | N/A | 7,300 | -200 |
| Purchase Of Investment | N/A | N/A | N/A | -217,200 | -52,700 |
| Sale Of Investment | N/A | N/A | N/A | 68,500 | 200 |
| Purchase Sale Intangibles | -1,790 | -1,526 | N/A | N/A | N/A |
| Other Investing Activity | -1,890 | -1,562 | 0 | 17,000 | -10,800 |
| Investing Cash Flow | $-2,248 | $-2,506 | $N/A | $-152,500 | $-90,200 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -700 | -2,700 |
| Common Stock Issued | 101,655 | -24 | N/A | N/A | N/A |
| Common Stock Repurchased | -141 | N/A | N/A | N/A | -94,100 |
| Other Financing Activity | -1,002 | 0 | 0 | -1,600 | 0 |
| Financing Cash Flow | $100,512 | $-24 | $N/A | $-2,300 | $-96,800 |
| Exchange Rate Effect | 61 | -53 | N/A | 800 | 11,200 |
| Beginning Cash Position | 138,807 | 262,752 | N/A | 535,500 | 631,400 |
| End Cash Position | 115,551 | 138,807 | N/A | 518,100 | 535,500 |
| Net Cash Flow | $-23,256 | $-123,945 | $N/A | $-17,400 | $-95,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | -121,581 | -121,362 | N/A | 136,600 | 79,900 |
| Capital Expenditure | -358 | -944 | N/A | -29,400 | -32,000 |
| Free Cash Flow | -121,939 | -122,306 | 0 | 107,200 | 47,900 |